United States Blood Culture Tests Market to hit US$ 8,600.93 Million by 2030 | Top Companies - Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories

"Blood Culture Tests Market was valued at USD 4357.91 million in 2022 and is estimated to reach USD 8600.93 million by 2030, growing at a CAGR of 9.1% during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/blood-culture-tests-market?sp

United States: Recent Industry Developments

✅ In November 2025, bioMérieux, Inc. launched its BacT/ALERT VIRTUO® 3D blood culture system with AI-powered detection and faster pathogen identification, reducing time to result for sepsis management. The system enhances laboratory efficiency and patient outcomes. It underscores bioMérieux's leadership in rapid diagnostic technologies.

✅ In October 2025, BD (Becton Dickinson) introduced an upgraded BD BACTECTM FX Plus system featuring improved sensor technology and automated reporting to accelerate bacterial and fungal detection. The innovation reduces turnaround time for critical blood culture testing. It reflects BD's focus on precision diagnostics and workflow optimization.

✅ In September 2025, Thermo Fisher Scientific expanded its automated blood culture solutions with enhanced molecular pathogen identification modules, supporting quicker antibiotic stewardship decisions in hospitals. The system integrates with existing lab infrastructure for seamless workflow. It highlights Thermo Fisher's commitment to rapid and reliable clinical microbiology.

✅ In August 2025, Siemens Healthineers deployed a cloud-connected blood culture testing platform for hospital networks, combining automated monitoring with AI-based predictive analytics to detect early bloodstream infections. The solution improves response times and patient management. It demonstrates Siemens' investment in smart, connected diagnostic tools.

Japan: Recent Industry Developments

✅ In November 2025, Sysmex Corporation launched an AI-assisted blood culture system in Japanese hospitals, enabling rapid detection of bacterial pathogens and automated data reporting. The platform enhances lab productivity and patient care. It reflects Japan's emphasis on intelligent, high-throughput diagnostic solutions.

✅ In October 2025, Fujifilm Wako Pure Chemical Corporation introduced an improved blood culture testing kit with faster incubation and high-sensitivity pathogen detection for clinical laboratories. The innovation supports quicker clinical decision-making in sepsis cases. It demonstrates Japan's focus on advanced diagnostics.

✅ In September 2025, Nipro Corporation expanded its blood culture analyzer lineup with automated monitoring, contamination detection, and integration with hospital information systems. The system reduces human error and improves laboratory workflow efficiency. It highlights Japan's commitment to precision blood culture testing.

✅ In August 2025, Olympus Corporation (Japan) piloted a next-generation blood culture monitoring platform for outpatient clinics and hospital labs, incorporating remote monitoring and predictive analytics for early infection detection. The system improves patient safety and operational efficiency. It underscores Japan's focus on cutting-edge diagnostic tools.

Blood Culture Tests Market: Drivers

The blood culture tests market is experiencing robust growth as timely and accurate detection of bloodstream infections becomes increasingly critical in clinical care. Blood culture tests are essential for diagnosing sepsis, bacteremia, and other serious infections, enabling appropriate antimicrobial therapy and improving patient outcomes. Rising prevalence of hospital-acquired infections, growing antimicrobial resistance, and increasing cases of immunocompromised patients are key drivers of market demand. The adoption of automated and rapid blood culture systems is improving turnaround times, sensitivity, and diagnostic accuracy. Additionally, the integration of advanced microbial identification and susceptibility testing is further enhancing clinical decision-making.

Technological advancements in blood culture testing, such as automated continuous-monitoring systems, molecular-based pathogen detection, and multiplex assays, are improving efficiency and reliability in laboratories. Hospitals and diagnostic centers are increasingly implementing point-of-care and near-patient testing solutions to accelerate diagnosis and treatment. The rising focus on antimicrobial stewardship programs and infection control protocols is supporting the use of rapid and precise blood culture diagnostics. Moreover, expanding healthcare infrastructure and laboratory networks in emerging markets are fueling market adoption. With continuous innovation, increasing infection awareness, and the need for early intervention, the blood culture tests market is poised for sustained, technology-driven growth in the coming years.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-culture-tests-market?sp

Blood Culture Tests Market: Major Players

Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, F. Hoffman-La Roche, Luminex Corporation, Bruker Corporation, OpGen Inc., T2 Biosystems Inc. and more.

Segment Covered in the Blood Culture Tests Market:

By Product
The market is segmented into Consumables, Blood Culture Media, Assay, Kits and Reagents, Blood Culture Accessories, Instruments, Equipment, Incubators, Microscopes, Colony Counters, Automated Blood Culture Systems, Software, and Services. Consumables and reagents dominate the market owing to their high utilization rates in daily testing processes, while automated blood culture systems are witnessing significant growth due to increased demand for faster and more accurate diagnostic results.

By Technology
Based on technology, the market includes Culture-based, Proteomic-based, Molecular-based, Polymerase Chain Reaction (PCR), and Microarray. The culture-based method remains the gold standard due to its accuracy and reliability in identifying microorganisms, whereas molecular-based and PCR techniques are rapidly expanding owing to their high sensitivity, rapid turnaround time, and suitability for detecting hard-to-culture pathogens.

By Application
The market is categorized into Bacterial Infection, Fungal Infection, Mycobacterial Infection, and Others. Bacterial infection testing holds the largest share due to the high prevalence of bloodstream infections globally, while fungal and mycobacterial testing segments are growing steadily with advancements in diagnostic technologies and increasing awareness of opportunistic infections.

By End-User
End-users include Hospital Laboratories, Private Laboratories, and Others. Hospital laboratories dominate the market due to the high patient influx and integrated testing facilities, whereas private laboratories are expanding rapidly driven by outsourcing of diagnostic services and the adoption of automated blood culture systems.

Research Process:

Both primary and secondary data sources have been used in the Blood Culture Tests Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Blood Culture Tests Market Research Industry:

➠ Who leads the Blood Culture Tests industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Blood Culture Tests market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Blood Culture Tests market growth?
➠ What are the dominant sales and distribution strategies in the Blood Culture Tests industry?

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=blood-culture-tests-market
(Purchase 2 or more Repots and get 50% Discount)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.